Shanghai No.1 Pharmacy Co.,Ltd. (SHA:600833)
8.98
-0.15 (-1.64%)
Nov 18, 2026, 3:00 PM CST
Shanghai No.1 Pharmacy Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 2,113 | 2,130 | 1,915 | 1,820 | 2,656 | 1,398 |
Revenue Growth | 1.32% | 11.23% | 5.26% | -31.49% | 89.94% | -11.89% |
Gross Profit Gross Profit Growth | 323.73 | 340.08 | 317.2 | 345.21 | 540.36 | 244.86 |
Operating Income Operating Income Growth | -13.57 | -5.97 | 11.93 | 11.41 | 206.63 | 8.94 |
Net Income Net Income Growth | 31.38 | 57.75 | 163.06 | 89.28 | 143.56 | 49.42 |
Earnings Per Share EPS Growth | 0.14 | 0.26 | 0.73 | 0.40 | 0.64 | 0.22 |
EPS Growth | -54.27% | -64.38% | 82.50% | -37.50% | 190.91% | -29.03% |
Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Pharmaceutical Retail Pharmaceutical Retail Growth | 1,268 |
Pharmaceutical Wholesale Pharmaceutical Wholesale Growth | 802.95 |
Total Total Growth | 2,070 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 365.24 | 421.67 | 537.41 | 496.47 | 765.22 | 262.28 |
Total Debt Total Debt Growth | 141.05 | 221.21 | 275.12 | 266.63 | 457.67 | 102.03 |
Net Cash (Debt) Net Cash Growth | 224.19 | 200.46 | 262.29 | 229.83 | 307.55 | 160.26 |
Net Cash Growth | -24.71% | -23.57% | 14.12% | -25.27% | 91.91% | -51.34% |
Net Cash Per Share Net Cash Per Share Growth | 1.01 | 0.90 | 1.17 | 1.03 | 1.37 | 0.71 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 67.8 | 88.88 | 49.03 | 58.49 | 132.31 | 36.56 |
Capital Expenditures CapEx Growth | -9.6 | -15.93 | -51.94 | -13.88 | -11.37 | -12.64 |
Free Cash Flow Free Cash Flow Growth | 58.2 | 72.95 | -2.91 | 44.61 | 120.94 | 23.92 |
Free Cash Flow Growth | -44.05% | - | - | -63.11% | 405.61% | -66.78% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 15.32% | 15.96% | 16.56% | 18.97% | 20.34% | 17.51% |
Operating Margin | -0.64% | -0.28% | 0.62% | 0.63% | 7.78% | 0.64% |
Pretax Margin | 1.89% | 3.57% | 11.29% | 6.46% | 7.17% | 4.67% |
Profit Margin | 1.49% | 2.71% | 8.51% | 4.91% | 5.41% | 3.53% |
FCF Margin | 2.75% | 3.43% | -0.15% | 2.45% | 4.55% | 1.71% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.078 | 0.078 | 0.220 | 0.125 | 0.195 | 0.070 |
Dividend Per Share Growth | -64.55% | -64.55% | 76.00% | -35.90% | 178.57% | -26.32% |
Dividend Yield | 0.87% | 0.60% | 1.63% | 1.04% | 1.73% | 0.75% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 63.56 | 49.95 | 18.47 | 30.04 | 17.53 | 42.21 |
P/FCF Ratio | 35.00 | 39.54 | - | 60.10 | 20.81 | 87.20 |
PS Ratio | 0.96 | 1.35 | 1.57 | 1.47 | 0.95 | 1.49 |